Polaryx Therapeutics PLYX
NASDAQ PLYX
$2.02 -0.05 (-2.42%)
At close: Oct 1, 2026 · 4:00 PM EDT

Polaryx Therapeutics (PLYX) Research & Development (2025 - 2026)

Updated

Polaryx Therapeutics' Research & Development came in at $719,000 for Q2 2026, up 51.1% from $476,000 a year earlier and up 5.9% from the prior quarter.

Analysis

Polaryx Therapeutics (PLYX) Research & Development (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Polaryx Therapeutics reported Research & Development of $6.59 million; for FY2025, it came in at $6.27 million, up 122.9% from FY2024.

  • Going back by year, Research & Development was $2.81 million in FY2024.
  • The Q2 2026 figure represents the highest quarterly Research & Development since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 3.65 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 2.34 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -4.05 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.76 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 993.80 Mn
10 Polaryx Therapeutics 103.18 Mn 78.80 Mn - 719,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 719,000.00
Mar 31, 2026 679,000.00
Jun 30, 2025 476,000.00
Mar 31, 2025 4.72 Mn
API Access

Polaryx Therapeutics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=PLYX&period=max&api_key=YOUR_API_KEY